临床指南
ENGLISH ABSTRACT
妊娠期高血压疾病诊治指南(2020)
中华医学会妇产科学分会妊娠期高血压疾病学组
作者及单位信息
·
DOI: 10.3760/cma.j.cn112141-20200114-00039
Diagnosis and treatment of hypertension and pre-eclampsia in pregnancy: a clinical practice guideline in China(2020)
Hypertensive Disorders in Pregnancy Subgroup, Chinese Society of Obstetrics and Gynecology, Chinese Medical Association
Authors Info & Affiliations
Hypertensive Disorders in Pregnancy Subgroup, Chinese Society of Obstetrics and Gynecology, Chinese Medical Association
·
DOI: 10.3760/cma.j.cn112141-20200114-00039
42546
15646
0
23
844
224
PDF下载
APP内阅读
摘要

妊娠期高血压疾病是全世界孕产妇和围产儿死亡的主要原因之一。中华医学会妇产科学分会妊娠期高血压疾病学组在2015版指南的基础上进行修订,并颁发妊娠期高血压及子痫前期临床诊治指南2020版。在2020版指南中,明确强调了妊娠期高血压疾病孕妇发病的背景复杂,尤其子痫前期-子痫存在多因素-多机制-多通路致病的综合征发病性质。不仅孕妇高血压的临床表现程度和表现形式复杂,子痫前期的首发症状也存在多样性。于此基础上,本指南在强调各种风险因素识别同时,提出应重视妊娠期的临床预警信息,强化产前检查,提高早期识别和早期诊断能力,并在降压和预防抽搐等对症处理的基础上,注意各种诱发病因的诊治。本指南旨在为妊娠期高血压及子痫前期的临床诊治提供指导,并扩展临床多方面诊治思路。

引用本文

中华医学会妇产科学分会妊娠期高血压疾病学组. 妊娠期高血压疾病诊治指南(2020)[J]. 中华妇产科杂志,2020,55(04):227-238.

DOI:10.3760/cma.j.cn112141-20200114-00039

PERMISSIONS

Request permissions for this article from CCC.

评价本文
*以上评分为匿名评价
本文评分
5 [累计2个]
中华医学会妇产科学分会妊娠期高血压疾病学组在《妊娠期高血压疾病诊治指南(2015)》 [ 1 ]的基础上,更新发布"妊娠期高血压疾病诊治指南(2020)"版本。本指南根据对妊娠期高血压疾病的新的认识,参考了美国、加拿大、英国、澳大利亚、国际妇产科联盟(FIGO)、WHO等最新的相关指南 [ 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 ],并结合我国国情、临床研究及实践经验,遵循循证医学理念,对有关的治疗方案给出了证据评价 [ 11 ]。本指南更加强调对妊娠期高血压疾病的临床预警和早期识别能力,强调早预警、早发现和早干预,进一步规范和指导我国妊娠期高血压疾病的临床处理。
本指南的循证证据等级及推荐建议:(1)证据等级:①Ⅰ:证据来自至少1个高质量的随机对照试验;②Ⅱ-1:证据来自设计良好的非随机对照试验;③Ⅱ-2:证据来自设计良好的队列(前瞻性或回顾性)研究或者病例对照研究;④Ⅱ-3:证据来自不同时间或地点干预措施效果的差异研究;⑤Ⅲ:基于临床经验、描述性研究或者专家委员会报告等的专家意见。(2)推荐建议:①A:证据适合推荐应用于临床预防;②B:证据较适合推荐应用于临床预防;③C:现有的证据间不一致;④D:有一定的证据不推荐用于临床预防;⑤E:有相当证据不推荐用于临床预防;⑥L:没有足够的证据(数量或质量)可以提出建议,但是,其他因素可能会影响决策。
试读结束,您可以通过登录机构账户或个人账户后获取全文阅读权限。
附录
2020年4期继续教育题目(一)(单项选择题):

1.妊娠相关高血压疾病概括为4类,包括妊娠期高血压(gestational hypertension)、子痫前期-子痫(pre-eclampsiaeclampsia)、妊娠合并慢性高血压(chronic hypertension)、慢性高血压伴发子痫前期(chronic hypertension with superimposed preeclampsia)。慢性高血压为孕妇存在的各种原因的继发性或原发性高血压,可以有不同的表现形式:( )

A.白大衣高血压

B.隐匿性高血压

C.短暂性高血压

D.产前检查时发现一过性高血压

E.以上表现都有可能

2.在产前检查时,孕妇的尿常规显示尿蛋白(+),不可能的原因是:( )

A.存在自身免疫性疾病

B.存在尿液污染可能

C.尿比重<1.030时

D.肾脏疾病

3.子痫前期首发的临床症状不可能表现为:( )

A.高血压伴有蛋白尿

B.单纯蛋白尿表现

C.单纯血压升高

D.胎儿生长正常

4.子痫发作前可能有哪些前驱症状:( )

A.持续性枕部头痛

B.持续性前额头痛

C.视物模糊、畏光

D.神经反射亢进

E.以上都有可能是子痫发作的前驱症状

5.重度子痫前期的临床表现不包括:( )

A.持续性头痛、视觉障碍

B.低蛋白血症伴腹水、胸水或心包积液

C.胎儿生长正常

D.微血管内溶血表现伴有贫血

(继续教育的答题方式及获得学分的方法见插页。答案见下期)

(2020年1期继续教育题目的答案:1.C 2.D 3.B 4.A 5.B)

参考文献
[1]
中华医学会妇产科学分会妊娠期高血压疾病学组. 妊娠期高血压疾病诊治指南(2015)[J]. 中华妇产科杂志, 2015,50(10):721-728. DOI: 10.3760/cma.j.issn.0529-567x.2015.10.001 .
返回引文位置Google Scholar
百度学术
万方数据
[2]
ACOG Practice Bulletin No. 202: gestational hypertension and preeclampsia[J]. Obstet Gynecol, 2019,133(1):e1-1e25. DOI: 10.1097/AOG.0000000000003018 .
返回引文位置Google Scholar
百度学术
万方数据
[3]
American College of Obstetricians and Gynecologists, Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' task force on hypertension in pregnancy[J]. Obstet Gynecol, 2013,122(5):1122-1131. DOI: 10.1097/01.AOG.0000437382.03963.88 .
返回引文位置Google Scholar
百度学术
万方数据
[4]
Magee LA , Pels A , Helewa M ,et al. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary[J]. J Obstet Gynaecol Can, 2014,36(7):575-576. DOI: 10.1016/S1701-2163(15)30533-8 .
返回引文位置Google Scholar
百度学术
万方数据
[5]
Butalia S , Audibert F , Côté AM ,et al. Hypertension Canada's 2018 guidelines for the management of hypertension in pregnancy[J]. Can J Cardiol, 2018,34(5):526-531. DOI: 10.1016/j.cjca.2018.02.021 .
返回引文位置Google Scholar
百度学术
万方数据
[6]
Webster K , Fishburn S , Maresh M ,et al. Diagnosis and management of hypertension in pregnancy: summary of updated NICE guidance[J]. BMJ, 2019,366:l5119. DOI: 10.1136/bmj.l5119 .
返回引文位置Google Scholar
百度学术
万方数据
[7]
Lowe SA , Bowyer L , Lust K ,et al. The SOMANZ guidelines for the management of hypertensive disorders of pregnancy 2014[J]. Aust N Z J Obstet Gynaecol, 2015,55(1):11-16. DOI: 10.1111/ajo.12253 .
返回引文位置Google Scholar
百度学术
万方数据
[8]
Brown MA , Magee LA , Kenny LC ,et al. Hypertensive Disorders of Pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice[J]. Hypertension, 2018,72(1):24-43. DOI: 10.1161/HYPERTENSIONAHA.117.10803 .
返回引文位置Google Scholar
百度学术
万方数据
[9]
Poon LC , Shennan A , Hyett JA ,et al. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first-trimester screening and prevention[J]. Int J Gynaecol Obstet, 2019,145Suppl 1:1-33. DOI: 10.1002/ijgo.12802 .
返回引文位置Google Scholar
百度学术
万方数据
[10]
WHO. WHO recommendations: Policy of interventionist versus expectant management of severe pre-eclampsia before term[M]. Geneva:World Health Organization, 2018.
[11]
Campos-Outcalt D Sr . US Preventive Services Task Force: the gold standard of evidence-based prevention[J]. J FamPract, 2005,54:517-519.
返回引文位置Google Scholar
百度学术
万方数据
[12]
Ding X , Yang Z , Han Y . et al., Long-chain fatty acid oxidation changes in a b2 glycoprotein I-induced preeclampsia-like mouse model[J]. Placenta, 2014,35(6):392-397.
返回引文位置Google Scholar
百度学术
万方数据
[13]
Metz TD , Allshouse AA , Euser AG ,et al. Preeclampsia in high risk women is characterized by risk group-specific abnormalities in serum biomarkers[J]. Am J Obstet Gynecol, 2014,211(5):512.e1-6. DOI: 10.1016/j.ajog.2014.04.027 .
返回引文位置Google Scholar
百度学术
万方数据
[14]
Conde-Agudelo A , Belizan JM . Risk factors for pre-eclampsia in a large cohort of Latin American and Caribbean women[J]. BJOG, 2000,107(1):75-83. DOI: 10.1111/j.1471-0528.2000.tb11582.x .
返回引文位置Google Scholar
百度学术
万方数据
[15]
Williams PJ , Broughton Pipkin F . The genetics of pre-eclampsia and other hypertensive disorders of pregnancy[J]. Best Pract Res Clin Obstet Gynaecol, 2011,25(4):405-417. DOI: 10.1016/j.bpobgyn.2011.02.007 .
返回引文位置Google Scholar
百度学术
万方数据
[16]
Ye C , Ruan Y , Zou L ,et al. The 2011 survey on hypertensive disorders of pregnancy (HDP) in China: prevalence, risk factors, complications, pregnancy and perinatal outcomes[J]. PLoS One, 2014,9(6):e100180. DOI: 10.1371/journal.pone.0100180 .
返回引文位置Google Scholar
百度学术
万方数据
[17]
Bartsch E , Medcalf KE , Park AL ,et al. Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies[J]. BMJ, 2016,353:i1753. DOI: 10.1136/bmj.i1753 .
返回引文位置Google Scholar
百度学术
万方数据
[18]
Magee LA , Hdewa M , Momquin JM ,et al. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy[J]. J obstetGynaeol Can, 2008,30:S1-S48. DOI: 10.1016/S1701-2163(16)32870-5 .
返回引文位置Google Scholar
百度学术
万方数据
[19]
Côté AM , Brown MA , Lam E ,et al. Diagnostic accuracy of urinary spot protein: creatinine ratio for proteinuria in hypertensive pregnant women: systematic review[J]. BMJ, 2008,336(7651):1003-1006. DOI: 10.1136/bmj.39532.543947.BE .
返回引文位置Google Scholar
百度学术
万方数据
[20]
Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy[J]. Am J Obstet Gynecol, 2000,183(1):S1-1S22.
返回引文位置Google Scholar
百度学术
万方数据
[21]
Morris RK , Riley RD , Doug M ,et al. Diagnostic accuracy of spot urinary protein and albumin to creatinine ratios for detection of significant proteinuria or adverse pregnancy outcome in patients with suspected pre-eclampsia: systematic review and meta-analysis[J]. BMJ, 2012,345:e4342. DOI: 10.1136/bmj.e4342 .
返回引文位置Google Scholar
百度学术
万方数据
[22]
庄旭林建华. 子痫前期孕妇24 h尿蛋白值与不良妊娠结局的相关性. 中华妇产科杂志 2014,49(7):538-540. DOI: 10.3760/cma.j.issn.0529-567x.2014.07.013 .
返回引文位置Google Scholar
百度学术
万方数据
[23]
庄旭陆漪婷陈云燕,. 子痫前期与妊娠合并慢性肾脏病孕妇血清免疫球蛋白、β2微球蛋白和转铁蛋白水平的比较[J]. 中华妇产科杂志, 2018,53(2):77-81. DOI: 10.3760/cma.j.issn.0529-567x.2018.02.002 .
返回引文位置Google Scholar
百度学术
万方数据
[24]
ACOG Practice Bulletin No. 204: fetal growth restriction[J]. Obstet Gynecol, 2019,133(2):e97-e109. DOI: 10.1097/AOG.0000000000003070 .
返回引文位置Google Scholar
百度学术
万方数据
[25]
陈扬杨孜宋颖,. 无严重并发症重度子痫前期终止妊娠指征影响因素分析[J]. 中国实用妇科与产科杂志, 2014,30(9):717-721.
返回引文位置Google Scholar
百度学术
万方数据
[26]
Churchill D , Beevers GD , Meher S ,et al. Diuretics for preventing pre-eclampsia[J]. Cochrane Database Syst Rev, 2007,(1):CD004451. DOI: 10.1002/14651858.CD004451.pub2 .
返回引文位置Google Scholar
百度学术
万方数据
[27]
McCoy S , Baldwin K . Pharmacotherapeutic options for the treatment of preeclampsia[J]. Am J Health Syst Pharm, 2009,66(4):337-344. DOI: 10.2146/ajhp080104 .
返回引文位置Google Scholar
百度学术
万方数据
[28]
Committee on Obstetric Practice. Committee Opinion No. 623: emergent therapy for acute-onset, severe hypertension during pregnancy and the postpartum period[J]. Obstet Gynecol, 2015,125(2):521-525. DOI: 10.1097/01.AOG.0000460762.59152.d7 .
返回引文位置Google Scholar
百度学术
万方数据
[29]
American College of Obstetricians and Gynecologists. Emergent therapy for acute-onset, severe hypertension during pregnancy and the postpartum period.Committee Opinion No. 692[J]. ObstetGynecol, 2017,129:e90-95.
返回引文位置Google Scholar
百度学术
万方数据
[30]
ACOG Committee Opinion No. 767: Emergent Therapy for Acute-Onset, Severe Hypertension During Pregnancy and the Postpartum Period[J]. Obstet Gynecol, 2019,133(2):e174-e180. DOI: 10.1097/AOG.0000000000003075 .
返回引文位置Google Scholar
百度学术
万方数据
[31]
Duley L , Gülmezoglu AM , Chou D . Magnesium sulphate versus lytic cocktail for eclampsia[J]. Cochrane Database Syst Rev, 2010,(9):CD002960. DOI: 10.1002/14651858.CD002960.pub2 .
返回引文位置Google Scholar
百度学术
万方数据
[32]
Duley L , Henderson-Smart DJ , Chou D . Magnesiumsulphate versus phenytoin for eclampsia[J]. Cochrane Database Syst Rev, 2010,6(10):CD000128. DOI: 10.1002/14651858 .
返回引文位置Google Scholar
百度学术
万方数据
[33]
Duley L , Gülmezoglu AM , Henderson-Smart DJ ,et al. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia[J]. Cochrane Database Syst Rev, 2010,(11):CD000025. DOI: 10.1002/14651858.CD000025.pub2 .
返回引文位置Google Scholar
百度学术
万方数据
[34]
Duley L , Henderson-Smart DJ , Walker GJ ,et al. Magnesium sulphate versus diazepam for eclampsia[J]. Cochrane Database Syst Rev, 2010,(12):CD000127. DOI: 10.1002/14651858.CD000127.pub2 .
返回引文位置Google Scholar
百度学术
万方数据
[35]
Ganzevoort W , Rep A , Bonsel GJ ,et al. A randomised controlled trial comparing two temporising management strategies, one with and one without plasma volume expansion, for severe and early onset pre-eclampsia[J]. BJOG, 2005,112(10):1358-1368. DOI: 10.1111/j.1471-0528.2005.00687.x .
返回引文位置Google Scholar
百度学术
万方数据
[36]
Churchill D , Beevers GD , Meher S ,et al. Diuretics for preventing pre-eclampsia[J]. Cochrane Database Syst Rev, 2007,(1):CD004451. DOI: 10.1002/14651858.CD004451.pub2 .
返回引文位置Google Scholar
百度学术
万方数据
[37]
Ho KM , Sheridan DJ . Meta-analysis of frusemide to prevent or treat acute renal failure[J]. BMJ, 2006,333(7565):420. DOI: 10.1136/bmj.38902.605347.7C .
返回引文位置Google Scholar
百度学术
万方数据
[38]
Ascarelli MH , Johnson V , McCreary H ,et al. Postpartum preeclampsia management with furosemide: a randomized clinical trial[J]. Obstet Gynecol, 2005,105(1):29-33. DOI: 10.1097/01.AOG.0000148270.53433.66 .
返回引文位置Google Scholar
百度学术
万方数据
[39]
中华医学会妇产科学分会产科学组. 胎膜早破的诊断与处理指南(2015)[J]. 中华围产医学杂志, 2015,18(3):161-167. DOI: 10.3760/cma.j.issn.1007-9408.2015.03.01 .
返回引文位置Google Scholar
百度学术
万方数据
[40]
WHO. WHO recommendations: Policy of interventionist versus expectant management of severe pre-eclampsia before term[M]. Geneva:World Health Organization, 2018.
[41]
Koopmans CM , Bijlenga D , Groen H ,et al. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial[J]. Lancet, 2009,374(9694):979-988. DOI: 10.1016/S0140-6736(09)60736-4 .
返回引文位置Google Scholar
百度学术
万方数据
[42]
Sezik M , Ozkaya O , Sezik HT ,et al. Expectant management of severe preeclampsia presenting before 25 weeks of gestation[J]. Med Sci Monit, 2007,13(11):CR523-527.
返回引文位置Google Scholar
百度学术
万方数据
[43]
Alanis MC , Robinson CJ , Hulsey TC ,et al. Early-onset severe preeclampsia: induction of labor vs elective cesarean delivery and neonatal outcomes[J]. Am J Obstet Gynecol, 2008,199(3):262.e1-6. DOI: 10.1016/j.ajog.2008.06.076 .
返回引文位置Google Scholar
百度学术
万方数据
[44]
史俊梅杨孜陈蕾. 重度子痫前期孕妇临床发病前预警信息分析[J],中华妇产科杂志 2009,44(5):337-340. DOI: 10.3760/cma.j.issn.0529-567x.2009.05.005 .
返回引文位置Google Scholar
百度学术
万方数据
[45]
Zeisler H , Llurba E , Chantraine F ,et al. Predictive vlue of the sFlt-1:PlGF ratio in women with suspected preeclampsia[J]. N Engl J Med, 2016,374(1):13-22. DOI: 10.1056/NEJMoa1414838 .
返回引文位置Google Scholar
百度学术
万方数据
[46]
Cnossen JS , Morris RK , ter Riet G ,et al. Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis[J]. CMAJ, 2008,178(6):701-711. DOI: 10.1503/cmaj.070430 .
返回引文位置Google Scholar
百度学术
万方数据
[47]
Rolnik DL , Wright D , Poon LC ,et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia[J]. N Engl J Med, 2017,377(7):613-622. DOI: 10.1056/NEJMoa1704559 .
返回引文位置Google Scholar
百度学术
万方数据
[48]
Sezik M , Ozkaya O , Sezik HT ,et al. Expectant management of severe preeclampsia presenting before 25 weeks of gestation[J]. Med Sci Monit, 2007,13(11):CR523-527.
返回引文位置Google Scholar
百度学术
万方数据
[49]
Berlin CM , Briggs GG . Drugs and chemicals in human milk[J]. Semin Fetal Neonatal Med, 2005,10(2):149-159. DOI: 10.1016/j.siny.2004.09.016 .
返回引文位置Google Scholar
百度学术
万方数据
备注信息
A
杨孜,北京大学第三医院妇产科 100191,Email: mocdef.6ab215002gnay_iz
B
张为远,首都医科大学附属北京妇产医院产科 100026,Email: mocdef.labiamtoh1299ywgnahz
C
所有作者均声明不存在利益冲突
评论 (0条)
注册
登录
时间排序
暂无评论,发表第一条评论抢沙发
MedAI助手(体验版)
文档即答
智问智答
机器翻译
回答内容由人工智能生成,我社无法保证其准确性和完整性,该生成内容不代表我们的态度或观点,仅供参考。
生成快照
文献快照

你好,我可以帮助您更好的了解本文,请向我提问您关注的问题。

0/2000

《中华医学会杂志社用户协议》 | 《隐私政策》

《SparkDesk 用户协议》 | 《SparkDesk 隐私政策》

网信算备340104764864601230055号 | 网信算备340104726288401230013号

技术支持:

历史对话
本文全部
还没有聊天记录
设置
模式
纯净模式沉浸模式
字号